Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?

References

• MooreJEKruijshaarMEOrmerodLPDrobniewskiFAbubakarIIncreasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995–2006BMC Public Health20101061220950421
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in ChildrenGenevaWHO2006 Available from: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.371_eng.pdfAccessed November 22, 2011
   Google Scholar
• WHOWHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and HouseholdsGenevaWHO2009 Available from: http://whqlibdoc.who.int/publications/2009/9789241598323_eng.pdfAccessed Oct 2011
   Google Scholar
• WHOWHO Revised TB Reporting and Recording RegistersGenevaWHO2006 Available from: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.373_eng.pdfAccessed Oct 2011
   Google Scholar
• WHOWHO Three I’s meeting Report of a Joint WHO HIV/AIDS and TB Department Meeting 2008GenevaWHO2008 Available from: http://www.who.int/hiv/pub/meetingreports/WHO_3Is_meeting_report.pdfAccessed Oct 2011
   Google Scholar
• WHOWHO Report 2011: Global Tuberculosis Control Available from: http://www.who.int/tb/publications/global_report/en/index.htmlAccessed Oct 2011
   Google Scholar
• European Centre for Disease Prevention and Control and WHOSurveillance Report: Tuberculosis Surveillance in Europe 2008StockholmEuropean Centre for Disease Prevention and Control2010 Available from: http://www.euro.who.int/_data/assets/pdf_file/0007/78856/E93600.pdfAccessed Nov 2011
   Google Scholar
• LawnSDZumlaAITuberculosisLancet20113789785577221420161
   PubMed Web of Science ®Google Scholar
• GandhiNRNunnPDhedaKMultidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisLancet201037597281830184320488523
   PubMed Web of Science ®Google Scholar
• ShahNSWrightABaiG-HWorldwide emergence of extensively drug-resistant tuberculosisEmerging Infect Dis200713338038717552090
   PubMed Web of Science ®Google Scholar
• NathansonENunnPUplekarMMDR tuberculosis – critical steps for prevention and controlN Engl J Med2010363111050105820825317
   PubMed Web of Science ®Google Scholar
• PrasadRMultidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutionsIndian J Tuberc201057418019121141336
   PubMedGoogle Scholar
• LönnrothKCastroKGChakayaJMTuberculosis control and elimination 2010–2050: cure, care, and social developmentLancet201037597281814182920488524
   PubMed Web of Science ®Google Scholar
• BatesMNKhalakdinaAPaiMChangLLessaFSmithKRRisk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysisArch Intern Med2007167433534217325294
   PubMedGoogle Scholar
• StevensonCRForouhiNGRoglicGDiabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidenceBMC Public Health2007723417822539
   PubMed Web of Science ®Google Scholar
• WilkinsonRJLlewelynMToossiZInfluence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control studyLancet2000355920461862110696983
   PubMed Web of Science ®Google Scholar
• LiuPTStengerSTangDHModlinRLCutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidinJ Immunol200717942060206317675463
   PubMed Web of Science ®Google Scholar
• WallisRSTumour necrosis factor antagonists: structure, function, and tuberculosis risksLancet Infect Dis200881060161118922482
   PubMed Web of Science ®Google Scholar
• NienhausASchablonATorres CostaJDielRSystematic review of cost and cost-effectiveness of different TB-screening strategiesBMC Health Serv Res20111124721961888
   PubMed Web of Science ®Google Scholar
• WHOTreatment of Tuberculosis: Guidelines4th ednGenevaWHO2010 Available from: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdfAccessed Nov 2011
   Google Scholar
• SteingartKRHenryMNgVFluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic reviewLancet Infect Dis20066957058116931408
   PubMed Web of Science ®Google Scholar
• WHOPolicy Framework for Implementing New Tuberculosis DiagnosticsGenevaWHO2011 Available from: http://www.who.int/tb/laboratory/whopolicyframework_rev_june2011.pdfAccessed Oct 2011
   Google Scholar
• MenziesDInterpretation of repeated tuberculin tests. Boosting, conversion, and reversionAm J Respir Crit Care Med1999159115219872812
   PubMed Web of Science ®Google Scholar
• LalvaniADiagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemyChest200713161898190617565023
   PubMed Web of Science ®Google Scholar
• DielRGolettiDFerraraGInterferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysisEur Respir J2011371889921030451
   PubMed Web of Science ®Google Scholar
• WHOThe STOP TB StrategyGenevaWHO2006 Available from: http://www.stoptb.org/assets/documents/resources/publications/plan_strategy/The_Stop_TB_Strategy_Final.pdfAccessed Nov 2011
   Google Scholar
• PintoLMenziesDTreatment of drug-resistant tuberculosisInfect Drug Resist2011412913521904458
   PubMedGoogle Scholar
• OrensteinEWBasuSShahNSTreatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisLancet Infect Dis20099315316119246019
   PubMed Web of Science ®Google Scholar
• SotgiuGFerraraGMatteelliAEpidemiology and clinical management of XDR-TB: a systematic review by TBNETEur Respir J200933487188119251779
   PubMed Web of Science ®Google Scholar
• NamH-SKohW-JKwonOJChoS-NShimTSDaily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosisInt J Antimicrob Agents2009331929318789655
   PubMed Web of Science ®Google Scholar
• SonnenbergPGlynnJRFieldingKMurrayJGodfrey-FaussettPShearerSHow soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold minersJ Infect Dis2005191215015815609223
   PubMed Web of Science ®Google Scholar
• LawnSDMyerLEdwardsDBekkerL-GWoodRShort-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South AfricaAIDS200923131717172519461502
   PubMed Web of Science ®Google Scholar
• MaartensGDecloedtECohenKEffectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countriesAntivir Ther20091481039104320032533
   PubMed Web of Science ®Google Scholar
• WHOGuidelines on Co-Trimoxazole Prophylaxis for HIV-related Infections among Children, Adolescents and Adults: Recommendations for a Public Health ApproachGenevaWHO2006 Available from: http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdfAccessed Nov 2011
   Google Scholar
• LawnSDBadriMWoodRTuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohortAIDS200519182109211616284460
   PubMed Web of Science ®Google Scholar
• LawnSDMyerLBekkerL-GWoodRBurden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS200620121605161216868441
   PubMed Web of Science ®Google Scholar
• Abdool KarimSSNaidooKGroblerAIntegration of antiretroviral therapy with tuberculosis treatmentN Engl J Med2011365161492150122010915
   PubMed Web of Science ®Google Scholar
• ShelburneSAMontesMHamillRJImmune reconstitution inflammatory syndrome: more answers, more questionsJ Antimicrob Chemother200657216717016354748
   PubMed Web of Science ®Google Scholar
• Aït-KhaledNAlarconEBissellKIsoniazid preventive therapy for people living with HIV: public health challenges and implementation issuesInt J Tuberc Lung Dis200913892793519723371
   PubMed Web of Science ®Google Scholar
• ConnellDWBerryMCookeGKonOMUpdate on tuberculosis: TB in the early 21st centuryEur Respir Rev201120120718421632795
   PubMedGoogle Scholar
• WallisRSPaiMMenziesDBiomarkers and diagnostics for tuberculosis: progress, needs, and translation into practiceLancet201037597291920193720488517
   PubMed Web of Science ®Google Scholar
• SalaCHartkoornRCTuberculosis drugs: new candidates and how to find moreFuture Microbiol20116661763321707310
   PubMed Web of Science ®Google Scholar
• KaufmannSHFact and fiction in tuberculosis vaccine research: 10 years laterLancet Infect Dis201111863364021798463
   PubMed Web of Science ®Google Scholar
• MaZLienhardtCMcIlleronHNunnAJWangXGlobal tuberculosis drug development pipeline: the need and the realityLancet201037597312100210920488518
   PubMed Web of Science ®Google Scholar
• MaraisBJRabieHCottonMFTB and HIV in children – advances in prevention and managementPaediatr Respir Rev2011121394521172674
   PubMed Web of Science ®Google Scholar
• ZhangTLiS-YWilliamsKNAndriesKNuermbergerELShort-course chemotherapy with TMC-207 and rifapentine in a murine model of latent tuberculosis infectionAm J Resp Crit Care Med Epub June 9, 2011
   Google Scholar
• DiaconAHPymAGrobuschMThe diarylquinoline TMC207 for multidrug-resistant tuberculosisN Engl J Med2009360232397240519494215
   PubMed Web of Science ®Google Scholar
• WilliamsKNBricknerSJStoverCKAddition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosisAm J Respir Crit Care Med2009180437137619520903
   PubMed Web of Science ®Google Scholar
• OnajoleOKGovenderPvan HeldenPDSynthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidatesEur J Med Chem20104552075207920149497
   PubMed Web of Science ®Google Scholar
• GothiDJoshiJMResistant TB: newer drugs and community approachRecent Pat Antiinfect Drug Discov201161273721192779
   PubMedGoogle Scholar
• DiaconAHDawsonRHanekomMEarly bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patientsInt J Tuberc Lung Dis201115794995421682970
   PubMed Web of Science ®Google Scholar
• MukherjeeTBoshoffHNitroimidazoles for the treatment of TB: past, present and futureFuture Med Chem20113111427145421879846
   PubMed Web of Science ®Google Scholar
• KaufmannSHHusseyGLambertP-HNew vaccines for tuberculosisLancet201037597312110211920488515
   PubMed Web of Science ®Google Scholar
• KernodleDSDecrease in the effectiveness of Bacille Calmette-Guérin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuationClin Infect Dis201051217718420524854
   PubMed Web of Science ®Google Scholar
• RowlandRMcShaneHTuberculosis vaccines in clinical trialsExpert Rev Vaccines201110564565821604985
   PubMed Web of Science ®Google Scholar
• ThaissCAKaufmannSHToward novel vaccines against tuberculosis: current hopes and obstaclesYale J Biol Med201083420921521165340
   PubMedGoogle Scholar
• DeselCDorhoiABandermannSGrodeLEiseleBKaufmannSHERecombinant BCG {Delta}ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responsesJ Infect Dis2011204101573158421933877
   PubMed Web of Science ®Google Scholar
• KaufmannSHFuture vaccination strategies against tuberculosis: thinking outside the boxImmunity201033456757721029966
   PubMed Web of Science ®Google Scholar
• KaufmannSHNovel tuberculosis vaccination strategies based on understanding the immune responseJ Intern Med2010267433735320433580
   PubMed Web of Science ®Google Scholar
• ParidaSKKaufmannSHThe quest for biomarkers in tuberculosisDrug Discov Today2010153–414815719854295
   PubMed Web of Science ®Google Scholar